Tianjin Hengrui Pharmaceutical

Tianjin Hengrui Pharmaceutical is a specialized subsidiary of Jiangsu Hengrui Pharmaceuticals, one of China's largest and most prominent pharmaceutical companies. The Tianjin-based entity focuses primarily on the development and large-scale manufacturing of high-quality pharmaceutical products, with a particular emphasis on respiratory treatments and inhaled formulations. The company operates advanced manufacturing facilities that comply with international GMP standards, supporting the parent company's broader portfolio in oncology, metabolic diseases, and inflammation. By leveraging the R&D capabilities of the Hengrui group, Tianjin Hengrui plays a critical role in the commercialization of both generic and innovative therapies for the Chinese and global markets.